BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19474390)

  • 1. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system.
    Yosten GL; Samson WK
    Am J Physiol Regul Integr Comp Physiol; 2009 Aug; 297(2):R330-6. PubMed ID: 19474390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural circuitry underlying the central hypertensive action of nesfatin-1: melanocortins, corticotropin-releasing hormone, and oxytocin.
    Yosten GL; Samson WK
    Am J Physiol Regul Integr Comp Physiol; 2014 May; 306(10):R722-7. PubMed ID: 24598461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nesfatin-1 stimulates renal sympathetic nerve activity in rats.
    Tanida M; Mori M
    Neuroreport; 2011 Apr; 22(6):309-12. PubMed ID: 21451359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermogenic effect of nesfatin-1 requires recruitment of the melanocortin system.
    Dore R; Levata L; Gachkar S; Jöhren O; Mittag J; Lehnert H; Schulz C
    J Endocrinol; 2017 Nov; 235(2):111-122. PubMed ID: 28851749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of nesfatin-1 are altered by stage of the estrous cycle.
    Pate AT; Schnell AL; Ennis TA; Samson WK; Yosten GLC
    Am J Physiol Regul Integr Comp Physiol; 2019 Aug; 317(2):R328-R336. PubMed ID: 31141415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of nesfatin-1-induced cardiovascular effects by the central cholinergic system.
    Aydin B; Guvenc G; Altinbas B; Niaz N; Yalcin M
    Neuropeptides; 2018 Aug; 70():9-15. PubMed ID: 29751997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nesfatin-1 activates cardiac vagal neurons of nucleus ambiguus and elicits bradycardia in conscious rats.
    Brailoiu GC; Deliu E; Tica AA; Rabinowitz JE; Tilley DG; Benamar K; Koch WJ; Brailoiu E
    J Neurochem; 2013 Sep; 126(6):739-48. PubMed ID: 23795642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronostatin acts in brain to biphasically increase mean arterial pressure through sympatho-activation followed by vasopressin secretion: the role of melanocortin receptors.
    Yosten GL; Pate AT; Samson WK
    Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1194-9. PubMed ID: 21325646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nesfatin-1 signaling in the basom edial amygdala modulates the gastric distension-sensitive neurons discharge and decreases gastric motility via melanocortin 3/4 receptors and modified by the arcuate nucleus.
    Xu L; Wang Q; Guo F; Pang M; Sun X; Gao S; Gong Y
    Eur J Pharmacol; 2015 Oct; 764():164-172. PubMed ID: 26144374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of nesfatin-1 as a satiety molecule in the hypothalamus.
    Oh-I S; Shimizu H; Satoh T; Okada S; Adachi S; Inoue K; Eguchi H; Yamamoto M; Imaki T; Hashimoto K; Tsuchiya T; Monden T; Horiguchi K; Yamada M; Mori M
    Nature; 2006 Oct; 443(7112):709-12. PubMed ID: 17036007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anorexigenic neuropeptide, nesfatin-1, is indispensable for normal puberty onset in the female rat.
    García-Galiano D; Navarro VM; Roa J; Ruiz-Pino F; Sánchez-Garrido MA; Pineda R; Castellano JM; Romero M; Aguilar E; Gaytán F; Diéguez C; Pinilla L; Tena-Sempere M
    J Neurosci; 2010 Jun; 30(23):7783-92. PubMed ID: 20534827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nesfatin-1 influences the excitability of neurons in the nucleus of the solitary tract and regulates cardiovascular function.
    Mimee A; Smith PM; Ferguson AV
    Am J Physiol Regul Integr Comp Physiol; 2012 Jun; 302(11):R1297-304. PubMed ID: 22442196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist.
    Yosten GL; Samson WK
    Am J Physiol Regul Integr Comp Physiol; 2010 Jun; 298(6):R1642-7. PubMed ID: 20335376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intermediary role of the central cyclooxygenase / lipoxygenase enzymes in intracerebroventricular injected nesfatin-1-evoked cardiovascular effects in rats.
    Guvenc-Bayram G; Yalcin M
    Neurosci Lett; 2021 Jun; 756():135961. PubMed ID: 34022265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.
    Stengel A; Goebel M; Wang L; Rivier J; Kobelt P; Mönnikes H; Lambrecht NW; Taché Y
    Endocrinology; 2009 Nov; 150(11):4911-9. PubMed ID: 19797401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice.
    Yamada-Goto N; Katsuura G; Ebihara K; Inuzuka M; Ochi Y; Yamashita Y; Kusakabe T; Yasoda A; Satoh-Asahara N; Ariyasu H; Hosoda K; Nakao K
    Diabetes; 2013 May; 62(5):1500-4. PubMed ID: 23274904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The melanocortin system is involved in regulating autonomic nerve activity through central pituitary adenylate cyclase-activating polypeptide.
    Tanida M; Shintani N; Hashimoto H
    Neurosci Res; 2011 May; 70(1):55-61. PubMed ID: 21291921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals.
    Goebel M; Stengel A; Wang L; Taché Y
    Peptides; 2011 Jan; 32(1):36-43. PubMed ID: 20933030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nesfatin-1 influences the excitability of ghrelin-responsive gastric distension neurons in the arcuate nucleus and reduces gastric motility in rats.
    Li ZL; Xu L; Sun XR; Guo FF; Gong YL; Gao SL
    Eur J Neurosci; 2013 Dec; 38(11):3636-43. PubMed ID: 24289827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones.
    Li SJ; Varga K; Archer P; Hruby VJ; Sharma SD; Kesterson RA; Cone RD; Kunos G
    J Neurosci; 1996 Aug; 16(16):5182-8. PubMed ID: 8756446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.